Temasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: BloombergTemasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: Bloomberg
Temasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: Bloomberg

In Singapore, Temasek’s results spark discussion of Chinese investments and Ho Ching

  • Even as it feels the sting of the US-China trade war, the state investment firm is staying true to its strategy of betting big on new trends
  • Its focus on China has mirrored Singapore’s transformation from an export-led economy to one focusing on domestic consumption and services

Topic |   Temasek Holdings
Temasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: BloombergTemasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: Bloomberg
Temasek has invested in BeiGene and Innovent Biologics, which develops therapies and antibodies for diseases such as cancer. Photo: Bloomberg
READ FULL ARTICLE